how many ml in a vial of tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Lilly launches lower-price weight-loss drug

MACE, major adverse cardiovascular event.

Patent protections for several leading medications are still active, although timelines vary by product and region

For people with a complex relationship between eating disorders and GLP-1 medications, treatment requires careful clinical consideration and a plan built around your individual circumstances

Therefore, we hypothesized whether GGCT expression is mediated by miRNAs (Fig

In addition, evidence of cognitive impairment in the prodromal stage and throughout the course of schizophrenia demonstrates a close relationship between cognitive impairment and independent living, social and community cognitive function, and functional outcomes (Green and Nuechterlein, 1999